https://www.selleckchem.com/pr....oducts/puromycin-ami
in patients who are living at home 3 months after stroke. The clinical rehabilitation impact depended on the setting and underlying goal which patient-reported outcome measure is preferred to evaluate HRQoL 3 months after stroke. The PROMIS-10 should be preferred to detect differences in less affected stroke patients, whereas the EQ-5D-5L provides slightly more information in more affected stroke patients. The clinical rehabilitation impact depended on the setting and underlying goal which patient-reported outcome meas
Like
Comment
Share
